Honestly I think we're on track to something a little bigger than what we're expecting. Would love to see this "equivalent of the rapid breakthrough review process to give the RadioGel review a priority" on the hopefully other indications that they'll apply for.
Like someone else mentioned before, it may be possible the FDA will approval multiple indications in a very short time with all the data and history they have with the FDA. Maybe not the big complex ones, but more simple indications.
I really want to sell during the hype spike if we get solid news, but I'm too scared that they'll come out of no where quickly with more good news and miss the run even more. I think you're crazy to sell just off of IDE or FDA approval news. Holding this a extra few years could really, really make the gains higher. Than again though, I'm the person who's away for work and can't day trade so that's just me.
News 
Market Data 
Discover 
